• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与来源于司帕沙星的膦配合的铜(I)配合物。第三部分:多方面的细胞死亡和选定铜(I)配合物的脂质体制剂的初步研究。

Copper(i) complexes with phosphine derived from sparfloxacin. Part III: multifaceted cell death and preliminary study of liposomal formulation of selected copper(i) complexes.

机构信息

Faculty of Chemistry, Jagiellonian University, Gronostajowa 2, 30-387 Kraków, Poland.

出版信息

Dalton Trans. 2018 Feb 6;47(6):1981-1992. doi: 10.1039/c7dt03917d.

DOI:10.1039/c7dt03917d
PMID:29345262
Abstract

The cytotoxic effect of iodide or thiocyanate copper(i) complexes (1-PSf, 2-PSf, 3-PSf, 4-PSf) with phosphine derived from sparfloxacin (HSf) and 2,9-dimethyl-1,10-phenanthroline (dmp) or 2,2'-biquinoline (bq) as diimine auxiliary ligands was proved in vitro on somatic (MRC-5) and neoplastic (MCF7) human cell lines. Differences in mode of action were investigated in-depth for the selected dmp and bq complexes (1-PSf, 3-PSf, respectively) by elucidation of the following: (i) the efficiency to produce reactive oxygen species (ROS) in biological systems (cyclic voltammetry); (ii) their impact on mitochondrial membrane potential; (iii) potency for the activation of caspases 3 and 9; (iv) influence on the degree of DNA degradation (comet assay). It was concluded that the apoptosis of cancer cells is directly connected to the caspase-dependent mitochondrial pathway and supported by ROS production along with irreversible DNA fragmentation. Finally, it was demonstrated that the selected copper(i) complex encapsulated inside liposomes (1-PSf-L) exhibited enhanced accumulation inside cancer cells. This resulted in its higher cytotoxicity against cancer cells with therapeutic index of ca. 60. Increased selective accumulation in active neoplasm with simultaneous enhanced bioavailability and reduced systemic toxicity of liposomal formulation of copper(i) complexes can result in the development of new copper-based therapeutics and their successful implementation in anticancer chemotherapy.

摘要

碘化物或硫氰酸根铜(I)配合物(1-PSf、2-PSf、3-PSf、4-PSf)与来源于司帕沙星(HSf)和 2,9-二甲基-1,10-菲咯啉(dmp)或 2,2'-联喹啉(bq)的膦作为二亚胺辅助配体的细胞毒性作用在体外对体细胞(MRC-5)和肿瘤细胞系(MCF7)进行了证明。通过阐明以下内容,深入研究了所选 dmp 和 bq 配合物(分别为 1-PSf 和 3-PSf)的作用方式:(i)在生物体系中产生活性氧物种(ROS)的效率(循环伏安法);(ii)它们对线粒体膜电位的影响;(iii)激活 caspase 3 和 9 的能力;(iv)对 DNA 降解程度的影响(彗星试验)。结论是癌细胞的凋亡与 caspase 依赖性线粒体途径直接相关,并通过 ROS 产生和不可逆的 DNA 片段化得到支持。最后,证明了包封在脂质体中的选定铜(I)配合物(1-PSf-L)在癌细胞内的积累增强。这导致其对癌细胞的细胞毒性增加,治疗指数约为 60。通过增加在活性肿瘤中的选择性积累,同时提高脂质体制剂的生物利用度和降低系统毒性,可能会开发出新的基于铜的治疗方法,并成功将其应用于癌症化疗中。

相似文献

1
Copper(i) complexes with phosphine derived from sparfloxacin. Part III: multifaceted cell death and preliminary study of liposomal formulation of selected copper(i) complexes.与来源于司帕沙星的膦配合的铜(I)配合物。第三部分:多方面的细胞死亡和选定铜(I)配合物的脂质体制剂的初步研究。
Dalton Trans. 2018 Feb 6;47(6):1981-1992. doi: 10.1039/c7dt03917d.
2
Copper(i) complexes with phosphine derived from sparfloxacin. Part I - structures, spectroscopic properties and cytotoxicity.铜(I)与源自司帕沙星的膦的配合物。第一部分——结构、光谱性质和细胞毒性。
Dalton Trans. 2015 Jul 28;44(28):12688-99. doi: 10.1039/c5dt01146a.
3
Copper(I) complexes with phosphine derived from sparfloxacin. Part II: a first insight into the cytotoxic action mode.铜(I)与源自司帕沙星的膦的配合物。第二部分:对细胞毒性作用模式的初步见解。
Dalton Trans. 2016 Mar 28;45(12):5052-63. doi: 10.1039/c5dt04011f.
4
Cu and Cu complexes with phosphine derivatives of fluoroquinolone antibiotics - A comparative study on the cytotoxic mode of action.铜和铜配合物与氟喹诺酮类抗生素的膦衍生物 - 细胞毒性作用模式的比较研究。
J Inorg Biochem. 2018 Apr;181:1-10. doi: 10.1016/j.jinorgbio.2018.01.008. Epub 2018 Jan 9.
5
Antibacterial activity and action mode of Cu(I) and Cu(II) complexes with phosphines derived from fluoroquinolone against clinical and multidrug-resistant bacterial strains.含膦配体的 Cu(I)和 Cu(II)配合物的抗菌活性和作用模式及其对临床和多药耐药菌的抑制作用。
J Inorg Biochem. 2020 Sep;210:111124. doi: 10.1016/j.jinorgbio.2020.111124. Epub 2020 Jun 2.
6
Selective Cu(I) complex with phosphine-peptide (SarGly) conjugate contra breast cancer: Synthesis, spectroscopic characterization and insight into cytotoxic action.含膦肽(SarGly)共轭物的选择性 Cu(I) 配合物抗乳腺癌:合成、光谱表征及细胞毒作用研究。
J Inorg Biochem. 2018 Sep;186:162-175. doi: 10.1016/j.jinorgbio.2018.06.009. Epub 2018 Jun 18.
7
Mixed ligand copper(II) complexes of N,N-bis(benzimidazol-2-ylmethyl)amine (BBA) with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity.N,N-双(苯并咪唑-2-基甲基)胺(BBA)与二亚胺共配体的混合配体铜(II)配合物:高效的化学核酸酶和蛋白酶活性及细胞毒性。
Inorg Chem. 2012 May 21;51(10):5512-32. doi: 10.1021/ic2017177. Epub 2012 May 4.
8
Induction of apoptosis in leukemia cell lines by new copper(II) complexes containing naphthyl groups via interaction with death receptors.含萘基的新型铜(II)配合物通过与死亡受体相互作用诱导白血病细胞系凋亡。
J Inorg Biochem. 2015 Dec;153:68-87. doi: 10.1016/j.jinorgbio.2015.09.014. Epub 2015 Oct 3.
9
Copper(I) complexes with phosphines P(p-OCH-Ph)CHOH and P(p-OCH-Ph)CHSarGly. Synthesis, multimodal DNA interactions, and prooxidative and in vitro antiproliferative activity.铜(I)配合物与膦 P(p-OCH-Ph)CHOH 和 P(p-OCH-Ph)CHSarGly。合成、多模态 DNA 相互作用以及促氧化和体外抗增殖活性。
J Inorg Biochem. 2020 Feb;203:110926. doi: 10.1016/j.jinorgbio.2019.110926. Epub 2019 Nov 15.
10
Mixed ligand copper(II) dicarboxylate complexes: the role of co-ligand hydrophobicity in DNA binding, double-strand DNA cleavage, protein binding and cytotoxicity.混合配体二羧酸铜(II)配合物:共配体疏水性在DNA结合、双链DNA切割、蛋白质结合和细胞毒性中的作用。
Dalton Trans. 2015 Jun 14;44(22):10210-27. doi: 10.1039/c4dt03879g.

引用本文的文献

1
Bilosomal Encapsulation of Binuclear Phosphino Ru(II)-Cu(II) Compounds Enhances Their Selectivity and Activity toward Lung and Prostate Cancers.双核膦基钌(II)-铜(II)化合物的脂质体包封增强了它们对肺癌和前列腺癌的选择性和活性。
J Med Chem. 2025 Jul 24;68(14):14442-14464. doi: 10.1021/acs.jmedchem.5c00486. Epub 2025 Jul 9.
2
ROS-producing nanomaterial engineered from Cu(I) complexes with PN-ligands for cancer cells treating.由含PN配体的Cu(I)配合物构建的用于癌细胞治疗的产ROS纳米材料。
Discov Nano. 2023 Oct 30;18(1):133. doi: 10.1186/s11671-023-03912-7.
3
Liposomal Binuclear Ir(III)-Cu(II) Coordination Compounds with Phosphino-Fluoroquinolone Conjugates for Human Prostate Carcinoma Treatment.
具有膦基-氟喹诺酮共轭物的脂质体双核 Ir(III)-Cu(II)配合物用于人类前列腺癌治疗。
Inorg Chem. 2022 Dec 5;61(48):19261-19273. doi: 10.1021/acs.inorgchem.2c03015. Epub 2022 Nov 16.
4
Copper(ii) complexes with 2-ethylpyridine and related hydroxyl pyridine derivatives: structural, spectroscopic, magnetic and anticancer studies.铜(II)与2-乙基吡啶及相关羟基吡啶衍生物的配合物:结构、光谱、磁性及抗癌研究
RSC Adv. 2022 Sep 28;12(42):27648-27665. doi: 10.1039/d2ra05133h. eCollection 2022 Sep 22.
5
Unravelling the anticancer potential of a square planar copper complex: toward non-platinum chemotherapy.揭示平面正方形铜配合物的抗癌潜力:迈向非铂类化疗
RSC Adv. 2021 Dec 10;11(62):39349-39361. doi: 10.1039/d1ra06227a. eCollection 2021 Dec 6.
6
Evaluation of anticancer activity in vitro of a stable copper(I) complex with phosphine-peptide conjugate.评估具有膦肽缀合物的稳定铜(I)配合物的体外抗癌活性。
Sci Rep. 2021 Dec 14;11(1):23943. doi: 10.1038/s41598-021-03352-2.
7
Interaction between DNA, Albumin and Apo-Transferrin and Iridium(III) Complexes with Phosphines Derived from Fluoroquinolones as a Potent Anticancer Drug.DNA、白蛋白和载脂蛋白转铁蛋白与铱(III)配合物之间的相互作用,该配合物含有源自氟喹诺酮类的膦,是一种有效的抗癌药物。
Pharmaceuticals (Basel). 2021 Jul 16;14(7):685. doi: 10.3390/ph14070685.
8
DNA-Binding and Cytotoxicity of Copper(I) Complexes Containing Functionalized Dipyridylphenazine Ligands.含功能化联吡啶吩嗪配体的铜(I)配合物的DNA结合与细胞毒性
Pharmaceutics. 2021 May 20;13(5):764. doi: 10.3390/pharmaceutics13050764.
9
Induction of Redox-Mediated Cell Death in ER-Positive and ER-Negative Breast Cancer Cells by a Copper(II)-Phenolate Complex: An In Vitro and In Silico Study.铜(II)-邻苯二酚配合物诱导 ER 阳性和 ER 阴性乳腺癌细胞发生氧化还原介导的细胞死亡:体外和计算研究。
Molecules. 2020 Oct 1;25(19):4504. doi: 10.3390/molecules25194504.
10
In vitro toxicity studies of biodegradable, polyelectrolyte nanocapsules.可生物降解的聚电解质纳米胶囊的体外毒性研究。
Int J Nanomedicine. 2018 Sep 6;13:5159-5172. doi: 10.2147/IJN.S169120. eCollection 2018.